LATEST NEWS
 Top Stories
 U.S.
  Severe Weather
  Bird Flu
 World
  Castro
  Mideast Crisis
  Iraq
 Business
 Personal Finance
 Technology
 Sports
  Sports Columns
  NASCAR
  Baseball
  College Hoops
  NBA
  NHL
  Tennis
  Golf
 Entertainment
 Health
 Science
 Politics
 Washington
 Offbeat
 Podcasts
 Blogs
 Weather
 Raw News
 NEWS SEARCH
 
 Archive Search
 SPECIAL SECTIONS
 Multimedia Gallery
 AP Video Network
 Today
 in History
 Corrections
Nov 13, 4:23 PM EST

Mattel and Qualcomm climb while GE and Baker Hughes drop


Interactives
Greece's Debt Threatens to Spread
State budget
gaps map
Auto industry problems trickle down, punish Tennessee county
Women give old Derby hats a makeover in tough economy
S.C. town deals with highest unemployment in South
How mortgages were bundled and sold as securities
Tracking the $700 billion financial bailout
Tracking the year's job losses
State-by-state foreclosures since 2007
Credit crisis explained
Presidents and their economic legacies
Lexicon of the financial crisis
Americans' addiction to debt

NEW YORK (AP) -- Stocks that moved substantially or traded heavily Monday:

General Electric Co., down $1.47 to $19.02

The industrial company cut its dividend in half and gave a disappointing profit forecast for 2018.

GGP Inc., up $1.85 to $24.05

Brookfield Property Partners offered to buy the rest of the shopping mall real estate investment trust for $14 billion.

Mattel Inc., up $3.02 to $17.64

The Wall Street Journal reported Friday that competitor Hasbro is interested in combining with Mattel.

Qualcomm Inc., up $1.92 to $66.49

The chipmaker said Broadcom's recent $103 billion offer is too low and that regulators might block a deal between them.

Tyson Foods Inc., up $1.45 to $75.59

The meat producer posted a larger profit and greater sales than analysts had expected.

Baker Hughes, a GE Co., down $1.07 to $31.88

General Electric, which owns most of the oilfield services company, said it may exit the business.

Nektar Therapeutics, up $4.60 to $37.10

The company reported positive clinical trial results for its experimental cancer drug NKTR-214.

WisdomTree Investments Inc., down 66 cents to $11.28

The asset management company said it will pay $611 million to buy a European division of ETF Securities.

© 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. Learn more about our Privacy Policy and Terms of Use.